The DOI matches its Crossref record; 192 of the 198 references it cites were found in a registry or an index.
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Open accessAbstract
homeostasis, autophagy, the release of nitric oxide and inflammatory mediators and altered gene and protein expression that involved apoptosis. Dox also causes downregulation of DNA methyltransferase 1 (DNMT1) enzyme activity which leads to a reduction in the DNA methylation process. This hypomethylation causes dysregulation in the mitochondrial genes like peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) unit in the heart. Apart from DNA methylation, Dox treatment also alters the micro RNAs levels and histone deacetylase (HDAC) activity. Therefore, in the current review, we have provided a detailed update on the current understanding of the pathological mechanisms behind the well-known Dox-induced cardiotoxicity. Further, we have provided some of the most plausible pharmacological strategies which have been tested against Dox-induced cardiotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cumulative anthracycline dose is a major risk factor for severe cardiomyopathy development but young age at treatment, female sex, peak drug exposure and additional stress to the heart have also been implicated 161,162,163 .”
From Osteosarcoma (2022) · cites this paper as [163]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty‐Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 261
RetractedChoi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803020200 · Cited by 85
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881
Research works printed but not linked: 6
- Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 26, 3777, 10.1200/JCO.2007.14.9401 · DOI
- Chustecka, 2006, Cardiotoxicity of imatinib is a" surprise, Nat. Med., 24
- Martínez-Mateo, 2017, Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely, J. Heart Health, 3
- Speth, 1988, Clinical pharmacokinetics of doxorubicin, Clin. Pharmacokinet., 15, 15, 10.2165/00003088-198815010-00002 · DOI
- Youngson, 2006, Collins dictionary of human biology, Collins
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI
Cited by
Sorted by citations
Items 601–700 of 915
Xu, H., Liu, Z., Zhuang, S., Chen, J., Geng, M., Han, X., Liu, Y., Guo, Y., Zheng, F., & Dai, Y. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153801 · Cited by 2
do Nascimento, J. S., de Sousa, A. P., Gondim, A. C. S., Sousa, E. H. S., Teixeira, E. H., Neto, L. G. D. N., Bezerra, B. P., Ayala, A. P., Batista, A. A., Vasconcelos, I. F., et al. (2022) · New Journal of Chemistry · doi:10.1039/d1nj04087a · Cited by 2
Tambekar, O. P., Shiranal, P., Muthal, A., Shinde, V. M., Kulkarni, R. G., Baikampady, S. V., & Bodhankar, S. L. (2023) · Toxicology International · doi:10.18311/ti/2023/v30i2/31316 · Cited by 2
VAR2HP recognizing heparin‐like epitopes in targeted therapy and diagnosis of tumors
Xu, Y., Liu, Y., Zou, R., Yuan, X., Wei, L., Qin, Y., Wang, X., Zhao, Y., Yang, Z., Wang, W., et al. (2024) · Proteoglycan Research · doi:10.1002/pgr2.16 · Cited by 2
Todorova, V. K., Bauer, M., Azhar, G., & Wei, J. Y. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155309 · Cited by 2
Ma, R., Wang, Y., Wang, Z., Yin, S., Liu, Z., & Yan, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070851 · Cited by 2
Ghane, M. S., Kianmehr, Z., Khorsandi, K., & Shahidi, F. K. (2025) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-025-00990-6 · Cited by 2
The Effects and Mechanisms of Indole Derivatives in Improving Doxorubicin-Induced Cardiomyopathy
Sun, J., Qian, F., Shi, F., Tang, O., Cheng, Y., Zhou, H., & Zhou, J. (2025) · Pharmacology · doi:10.1159/000546061 · Cited by 2
Xinmailong injection ameliorates Doxorubicin‑induced cardiotoxicity via the MDH2/OAA pathway
Liu, S., Xie, S., Sun, T., Wang, Y., Zhou, W., Yang, Y., Zhang, B., & Li, W. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157010 · Cited by 2
Moossavi, M., Zhu, P., Ding, Y., Mondaca‐Ruff, D., Yan, F., Ma, X., & Xu, X. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.08.005 · Cited by 2
Thymoquinone chemically conjugated to doxorubicin: antitumor activity and subcellular localization
Mahmoud, I. S., Nsairat, H., Alsotari, S. T., Jaber, A. M., Esawi, E., Abdelnabi, H., Holi, M. A., Soubani, F. E., Alshaer, W., & Odeh, F. (2025) · RSC Advances · doi:10.1039/d5ra05492c · Cited by 2
Varghese, R., Dalvi, Y. B., Vijay, N., & Gowda, V. (2023) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v61i08.3873 · Cited by 2
Lv, X., Wu, X. S., Liu, K., Zhao, X., Pan, C., Zhao, J., Chang, J., Guo, H., Gao, X., Zhi, X., et al. (2023) · Cancer Innovation · doi:10.1002/cai2.89 · Cited by 2
Александровна, К. И., Snezhitsky, V. A., Kurbat, M. N., Горустович, О. А., & Babenka, A. S. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-5579 · Cited by 2
Anthracycline-Induced Cardiomyopathy in Cancer Survivors: Management and Long-Term Implications
Mohsenizadeh, S. A., Rajaeinejad, M., Khoshfetrat, M., Arefizadeh, R., Mousavi, S. H., Mosaed, R., Kazemi-Galougahi, M. H., Jalaeikhoo, H., Faridfar, A., Nikandish, M., et al. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_804 · Cited by 2
Oliveira, V. D. G., Muxfeldt, M., da Paz, M. M., Coutinho, M. S., dos Santos, R. E., Ferretti, G. D. S., da Costa, D. C. F., Regufe, P. F., Gama, I. L., Boechat, F. D. C. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126490 · Cited by 2
Yang, Y., Wei, S., Liu, S., Xie, S., Xiao, W., Liu, J., Xie, N., Li, W., & Zhang, B. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.10.004 · Cited by 2
The Protective Effects of Carvacrol Against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
Retnosari, R., Ghani, M. A. A., Alkharji, M. M., Nawi, W. N. I. S. W., Rushdan, A. S. A., Mahadi, M. K., Ugusman, A., Oka, N., Zainalabidin, S., & Latip, J. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09940-8 · Cited by 2
Cai, W., Teng, T., Wang, X., Li, B., Gu, X., & Zhou, Y. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09947-1 · Cited by 2
Debia, N., Sousa, A. B. S., de Melo, B. A. C., de Sousa, A. A., Nobre, T. A., de Oliveira, V. A., de Almeida, J. O. C. S., de Souza, J. S. N., Arcanjo, D. D. R., Alves, M. M. D. M., et al. (2025) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2025.2496959 · Cited by 2
Çoşkun, R., Çelik, A. İ., Coşgun, M. S., Dündar, C., Türkoğlu, M., & Süleyman, H. (2022) · Koşuyolu Heart Journal · doi:10.51645/khj.2022.m210 · Cited by 2
Qaracheh, R. A., Fathi, M., & Rahmati, M. (2022) · Complementary Medicine Journal · doi:10.32598/cmja.12.2.615.2 · Cited by 2
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.05.030 · Cited by 2
Dong, L., & Liu, H. (2023) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.57.3.96 · Cited by 2
Özenver, N., Ünlü, S., Gündoğdu, S., & Demirezer, L. Ö. (2024) · Food and Health · doi:10.3153/fh24008 · Cited by 2
Chen, Z., Liu, Y., Ma, R., Zhang, M., Wu, X. G., Pen, H., Gui, F., Liu, Y., Xia, H., Hu, N., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230675 · Cited by 2
Al‐Oanzi, Z. H. (2023) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2023.36.1.reg.031-038.1 · Cited by 2
Luan, Y., Ding, X., Zhang, L., Huang, S., Yang, C., Tang, Y., Xing, L., Zhang, H., & Liu, Z. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03016-8 · Cited by 1
Recent findings of cardiac dysfunction and anti-cancer therapy
Papierkowska, J., Gawełczyk, W., & Soczyńska, J. (2024) · Medical Journal of Cell Biology · doi:10.2478/acb-2024-0007 · Cited by 1
Mahmoud, M. S., Morsy, M., Abdel‐Ghany, M., Idriss, N. K., Helmy, H. A. R., & Kishk, Y. T. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2466379 · Cited by 1
Nanosensing doxorubicin: a new frontier in medicinal chemistry
Karzad, N., Rastmanesh, S., Shaterian, E., Shaterian, H., & Mobed, A. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03421-5 · Cited by 1
Alikhani, M., Nazari, M., Nekooei, S., Abnous, K., Taghdisi, S. M., Toosi, F. S., Ramezani, M., & Alibolandi, M. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00743-9 · Cited by 1
From Mechanisms to Treatment: A Comprehensive View of Lymphatic Metastasis in Cancer
Devisetti, N., Shah, P., & Liu, F. C. (2025) · Lymphatics · doi:10.3390/lymphatics3020012 · Cited by 1
Samra, Y. A., Salam, A. S. G. A. E., Abdelghany, A. M., & El‐Shishtawy, M. M. (2025) · Discover Oncology · doi:10.1007/s12672-025-02447-w · Cited by 1
Song, J., Lee, J., Lee, S., Hwang, J.-T., Kim, M., Myoung, J., Lee, S., & Choi, H. (2025) · Journal of Medicinal Food · doi:10.1089/jmf.2025.k.0031 · Cited by 1
Yang, Y., Ding, Y., & Zhang, T. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00245a · Cited by 1
Yu, S., Mody, H. R., Vaidya, T. R., Kagan, L., & Ait‐Oudhia, S. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70087 · Cited by 1
FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity
Sheng, S., Wu, X., Xiao, C., Li, J., Ke, C., Hu, X., & Ni, C. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.07.018 · Cited by 1
Shokri, N., Mohammadi, A., Rajabi, A., Zenjanab, M. K., Fathi, M., & Safaralizadeh, R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10975-5 · Cited by 1
Stoyanov, B. P., Stefanova, D., Bogdanova, R., & Tzankova, V. (2025) · Acta Medica Bulgarica · doi:10.2478/amb-2025-00061 · Cited by 1
Nano-biohybrid systems for the targeted delivery of chemotherapeutics
Ou, Y.-H., Chng, W. H., Muthuramalingam, R. P. K., Liang, J., Lee, C. K., Yau, J. N. N., & Pastorin, G. (2025) · Nanoscale · doi:10.1039/d5nr02316e · Cited by 1
Çınar, İ., Akyel, S., & Dinçer, B. (2025) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1717960 · Cited by 1
Badr, N. H., Youssef, M. E., Shaaban, A. A., & El‐Kashef, H. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178200 · Cited by 1
Liu, J., Wang, Y., Wei, X., Liu, S., Hu, C., Peng, P., Wu, W., Cai, J., & Sun, H. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01114-0 · Cited by 2
Zhang, J., Li, X., Sun, L., Liu, H., Jia, T., Shen, H., Kang, B., Yang, Y., Guo, X., Huang, R., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120751 · Cited by 1
Ubiquitin E3 Ligases and p53 in Doxorubicin-Induced Cardiotoxicity
Tachibana, S., Otaki, Y., Goto, J., Watanabe, T., & Watanabe, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110252 · Cited by 1
Qaed, E., Mahyoub, M. A., Naji, W. Q. A., Wang, F. H., Liu, W., Aldahmash, W., Tang, Z., & Almoiliqy, M. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103207 · Cited by 1
Alanazi, M., Wu, M., Tian, D., Zhang, H., Yong, J., Xu, Z. P., & Zhang, R. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03823 · Cited by 1
Wang, C., Li, Y., Shen, X., Xiao, S., Du, H., Zhao, Q., Wang, Y., Zhang, Q., & Wen, S. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214588 · Cited by 1
Han, J., Li, X., Dong, Y., Wang, Y., Lv, S., Zhang, Y., Zhao, R., Yan, Y., Han, Y., Wang, Y., et al. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025223 · Cited by 1
Baniasadi, M., Rakhshan, K., Afousi, A. G., Imani, A., & Vakili, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-28394-8 · Cited by 1
Asbagh, A. G., Tabatabaei, K., Vaez, H., Jafarizadeh, A., Saeedi, H., Shokouhi, B., & Baradaran, B. (2025) · Breast Cancer Basic and Clinical Research · doi:10.1177/11782234251393421 · Cited by 1
Feng, Z., Sun, J., Geng, Q., He, B., Zhang, J., Ainiwaer, Y., Zhang, B., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-31983-2 · Cited by 1
Xing, J., Wang, Z., Ma, Y., Huang, M., Xiao, Y., Zhang, L., Sun, J., He, Z., Sun, B., & Li, L. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112386 · Cited by 1
Mohammad Firoz, A. L. A. M., Anwer, T., Mawkili, W., Qadri, M. M., Khardali, A., Alshamrani, A. A., Alshahrani, S., Hazazi, A. M. A., Thaibah, H. A., Ibrahim, S., et al. (2026) · International Journal of Food Science & Technology · doi:10.1093/ijfood/vvaf243 · Cited by 1
Ahmad, N. B., Sawamura, S., Ogata, G., Ōta, T., Tokudome, K., Moriyama, H., Tanaka, I., Ikarashi, K., Takai, M., Kita, S., et al. (2026) · ACS Sensors · doi:10.1021/acssensors.5c01392 · Cited by 1
Bian, S., Li, X. Z., Zhu, P., Jiang, Z., Yan, C., Wei, S., Luo, L., Zhu, Y., & Luo, L. (2026) · Human Cell · doi:10.1007/s13577-026-01362-8 · Cited by 1
GSK-3α activation mitigates Doxorubicin-induced cardiomyopathy through Keap1/Nrf2/HO-1 axis
Marzook, H., Dawuod, O. I., Mohammed, A. K., Karim, A., Taneera, J., Saleh, M. I., Qaisar, R., & Ahmad, F. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124317 · Cited by 1
Babu, A. D., ALI, A., Gaddipati, G. N., Jadhav, R., Tallapalli, J. R., Sainatham, C., Iliescu, C. A., Chatila, K., Deswal, A. M., & Khalife, W. (2026) · Journal of Cardiac Failure - Intersections · doi:10.1016/j.yjcafi.2026.02.015 · Cited by 1
Liu, Z., Wang, X., Zhou, X., Li, J., Luo, Q., Zhang, S., Zhu, Y., & Jiang, W. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107184 · Cited by 1
Shaban, A. M., Ali, E., Khalil, M. M. I. M., Omar, M., Al-Ghalban, Y. A. R., & Elgizawy, E. I. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2648210 · Cited by 1
Park, J. W., Jang, S. Y., Kim, M. Y., Yi, H. J., Sonn, S. K., Kweon, O., Lee, B., Oh, G. T., Woo, H. A., & Chang, T. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104176 · Cited by 1
Zhang, X.-C., Jiang, L.-C., Song, J.-X., Peng, J., Ni, K., Shen, F., & Zhou, C. (2026) · Current Neuropharmacology · doi:10.2174/011570159x414493251121073748 · Cited by 1
Akhtari, N., Sheykholeslami, S. E., Sablagh, Y. A. I., Mohammadgholi, A., Mansouri, A., Abbasi, H., & Noorbazargan, H. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10715-7 · Cited by 1
Леонидович, П. П., Shiabiev, I., Pysin, D., Arshinova, E., Mostovaya, O. A., Khannanov, A., Babaeva, O. B., Ranishenka, B. V., Stanavaya, A., Abashkin, V., et al. (2026) · Materials Today Chemistry · doi:10.1016/j.mtchem.2026.103664 · Cited by 1
Shi, Y., Xu, S., Li, C., Zhao, J., Hou, Y., Zhu, H., Wang, Y., Zhuo, M., He, S., & Hou, X. (2026) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2026.140813 · Cited by 1
Helal, A. M., Aborhyem, S. M., Makhlof, M. E. M., Ahmed, S. I., Akl, F. M. A., & Khedr, Y. I. (2026) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2026.100297 · Cited by 1
The gut–heart axis in cardio-oncology
Chan, N. S. L., Cross, C., Bowen, J., Prestidge, C. A., Ryan, F. J., Dorraki, M., Liyanage, S., Sharma, S., Pathy, R., Bursill, C. A., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag146 · Cited by 1
Toumari, L., Heidari‐Bakavoli, A., Askari, V. R., Khodadadi, H., Sobhani, B., Babaei, M., Mohajeri, S. A., Keihanian, F., & Rahimi, V. B. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107391 · Cited by 1
Conference, I. (2022) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2022.155718.6734 · Cited by 1
Eltablawy, N. A., Sayed, I. E. T. E., Barry, H. M. A., Ibrahim, M. A., & ElDein, M. N. A. S. (2022) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2023/11.1.176.188 · Cited by 1
Alyasari, N. K. H., & Almzaiel, A. J. (2023) · Al- Anbar Medical Journal · doi:10.33091/amj.2023.141684.1254 · Cited by 1
Intraoperative Bone Cement Implantation Syndrome in a Pediatric Patient
Tansey, P. J., Wainwright, J. D., Johnson, B. A., & Montgomery, N. I. (2024) · JBJS Case Connector · doi:10.2106/jbjs.cc.24.00390 · Cited by 1
Targeting breast cancer senescence in 3D models of bone metastasis
Hamburger, E. C. B., Garakani, M. M., Ghazizadeh, S., Alfaisali, S., Ouellet, J. A., Weber, M. H., Garzia, L., Haglund, L., & Rosenzweig, D. H. (2026) · Breast Cancer · doi:10.1007/s12282-026-01857-0 · Cited by 1
A promising platform of hypoxia sensitive magnetosomes in hepatocellular carcinoma therapy
Deng, K., Wang, J., Zhou, X., Geng, Y., Liu, W., Zhang, Y., Liu, Y., & Jiang, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-10353-y · Cited by 1
Sun, Z., Lin, J., Huang, Y., Liu, Q., Zhu, X., Yang, Y., Wen, Y., Shao, C., Liao, W., Song, Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165895 · Cited by 1
Emanet, H., DiPietro, F., Philip, S., & Acun, A. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01854-8 · Cited by 1
Acylhydrazone Derivatives: An Overview of Biological Activities
Luong, L. Q., Linh, P. T. K., Phuong, C. T. H., Ngoc, N. T., & Vu, T. K. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072409057250813101844 · Cited by 1
Alsaikhan, F. (2025) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-025-00573-y · Cited by 1
Fhatonah, N., Rustandi, T., Abdelmohsen, U. R., Rasydy, L. O. A., Ma'sum, M., Elghanam, Y., Pashar, I., Nordin, Mahal, A., & Riski, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1694322 · Cited by 1
Harrod, C. K., Hernandez, B. Y., Yates, C., & Harrod, R. (2025) · Journal of Experimental Pharmacology · doi:10.2147/jep.s546622 · Cited by 1
Safwan, M., Bourgleh, M. S., Alshakaki, H., & Haider, K. H. (2025) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2025.421 · Cited by 1
Wu, R., Bostani, A., & Wang, J. (2026) · Cancer Management and Research · doi:10.2147/cmar.s567591 · Cited by 1
Yang, Q., Zhao, S., Zhao, J., Shen, Y., Hong, Y., Qiu, J., Li, Z. L., Lin, F., Ma, K., Hu, B., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.01.030 · Cited by 1
Role of Perindopril in Mitigating Doxorubicin’s Vascular Toxicity in a Rat Model
Marada, A., Stračina, T., Marhefka, F., Šůstková, L., Nádeníček, J., Smutná, J., Scheer, P., Hložková, J., Hendrych, M., Studenik, C. R., et al. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10092-0 · Cited by 1
Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy
Wu, Y., SUN, X., Wang, R. X., Reddy, J. S., Lee, H.-C., Norton, N., & Lu, T. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005334 · Cited by 1
Shyam, M., Amrutha, M., Kommoju, N., Joshi, R. V., Srirangan, P., Vidya, R., Vashishth, R., & Prince, S. E. (2026) · Drug Metabolism Reviews · doi:10.1080/03602532.2026.2627345 · Cited by 1
Ronan, G., Celebi, L. E., Kowalczyk, N., Behnam, N., Hawthorne, L., Yang, J., Ketchum, F., Lowery, A., Kerin, M. J., & Zorlutuna, P. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.08.049 · Cited by 1
Sun, X., Wang, Y., Yang, Q., Xin, B., Huang, J., & Guo, C. (2026) · Phytotherapy Research · doi:10.1002/ptr.70276 · Cited by 1
Experimental evaluation of N-acetylcysteine against doxorubicin cardiotoxicity in rats
Tola, H. T., & Kılıç, S. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01073-0 · Cited by 1
Li, Y., Qin, J., Zhou, Y., Fang, B., Wang, K., Wu, S., Qian, H., Xing, G., Li, X., Ye, Z., et al. (2026) · Journal of Materials Science · doi:10.1007/s10853-026-12940-4 · Cited by 1
Darrah, M. A., Mahoney, S. A., Venkatasubramanian, R., VanDongen, N. S., Ludwig, K. R., Seals, D. R., Rossman, M. J., & Clayton, Z. S. (2026) · Aging Cell · doi:10.1111/acel.70535 · Cited by 1
Zhang, S., Li, R., Wu, K., Zhao, H., Song, J., Zhang, Y., Chen, Y., He, J., Kong, F., & Liu, Y. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152584 · Cited by 1
Kale, O. E., Gündüz, M. G., Osonuga, I. O., Awodele, O., & Ekor, M. (2026) · Human & Experimental Toxicology · doi:10.1177/09603271261446916 · Cited by 1
Lin, R., Li, Y., Liu, X., Meng, F., Wang, X., 蒋田南, 蒋田南, Liu, C., Jin, S., Liu, T., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.320 · Cited by 1
Complexed rifampicin with iron mitigates doxorubicin-induced nephrotoxicity
Basal, O. A., Saad, E. A., & Sadda, R. R. E. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01161-9 · Cited by 1
AlMutairi, M. M., Alkreathy, H. M., Shaik, R. A., Alharbi, A. E., & Magadmi, R. M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1843282 · Cited by 1
Jiang, M., Jiang, S., Ye, X., Qian, X., & Li, J. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179136 · Cited by 1
Metal‐Based Materials for Redox Modulation in Biomedicine
Fan, Y., Zhang, J., Sun, N., Chen, M., Sun, L., Lin, J., Chen, K., & Zhang, H. (2026) · Rare Metals · doi:10.1002/rar2.70536 · Cited by 1
Tang, J., Li, Z., Shang, Y., Li, J., Pan, R., Ye, H., Cao, G., Sun, Y., Ran, Z., Li, X., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181791 · Cited by 1
Metadata
- Authors
- Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U.
- Affiliations
- Central University of Punjab (IN)
- P.V. Narsimha Rao Telangana Veterinary University (IN)
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 139
- Pages
- 111708
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3160992829
- Cited by
- 909
- References
- 198
- Citations by year
- 2026: 171 · 2025: 232 · 2024: 208 · 2023: 193 · 2022: 92 · 2021: 13
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Royal Society of Medicine
- University of Central Punjab (GP-25)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- doxorubicin, cardiotoxicity, molecular mechanisms, DNA methylation, DNMT1, mitochondrial dysfunction, PGC-1α, NRF1, TFAM, microRNA, histone deacetylase, autophagy, apoptosis, nitric oxide, inflammatory mediators, cardioprotection, anthracycline chemotherapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Doxorubicin, Humans, Mitochondria, Heart, Apoptosis, Oxidative Stress, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review